Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02841163
Other study ID # JS-CT-2016-06
Secondary ID
Status Completed
Phase
First received
Last updated
Start date April 2016
Est. completion date January 2017

Study information

Verified date July 2022
Source Jaseng Medical Foundation
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Measurement of herniated disc resorption and assessment of satisfaction regarding post-treatment state and integrative Korean medicine treatment through phone interview in 500 patients with MRI follow-up results receiving treatment for lumbar and cervical disc herniation at Jaseng Hospital of Korean Medicine.


Description:

Intervertebral disc herniation treatment can be largely divided into conservative and surgical approaches, and the greater majority of patients show relief of symptoms and resorption of herniated disc through non-surgical, conservative management. Despite concerns that early surgical interventions in intervertebral disc herniation without allowing for sufficient conservative treatment may indicate overtreatment, awareness and understanding in the general public is found somewhat lacking. The objective of this study is to measure herniated disc resorption and assess satisfaction regarding post-treatment state and integrative Korean medicine treatment through phone interview in 500 patients with MRI follow-up results before and after receiving conservative treatment for lumbar and cervical disc herniation at Jaseng Hospital of Korean Medicine.


Recruitment information / eligibility

Status Completed
Enrollment 505
Est. completion date January 2017
Est. primary completion date October 2016
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Lumbar and/or cervical disc herniation patients with baseline MRI and follow-up results after receiving treatment at Jaseng Hospital of Korean Medicine visiting between February 2012 and December 2015. - Participants giving informed written consent to use of medical records for academic means. Exclusion Criteria: - Participants refusing to participate in study or to respond to phone interview.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Herbal medicine
Herbal medicine was administered 2-3 times daily in water-based decoction (120ml) and dried powder (2g) form (Ostericum koreanum, Eucommia ulmoides, Acanthopanax sessiliflorus, Achyranthes japonica, Psoralea corylifolia, Saposhnikovia divaricata, Cibotium barometz, Lycium chinense, Boschniakia rossica, Cuscuta chinensis, Glycine max, Atractylodes japonica).
Procedure:
Acupuncture
Acupuncture treatment was administered 1-2 times daily using mainly proximal acupuncture points and Ah-shi points.
Pharmacopuncture
Select herbal ingredients (Eucommia ulmoides cortex, Acanthopanax sessiliflorum cortex, Achyranthis bidentata radix, Saposhnikovia divaricata radix, Cibotium barometz rhizoma, Paeonia albiflora radix alba, Ostericum koreanum radix, Angelica pubescens radix, and Scolopendra subspinipes corpus (Paeonia albiflora twice the proportion of that of other ingredients)) were freeze dried into powder form after decoction, then diluted in water-for-injection and adjusted for acidity and pH. Pharmacopuncture was administered once daily at Hyeopcheok (Huatuo Jiaji, EX B2), Ah-shi points and local acupuncture points using disposable injection needles (CPL, 1 cc, 26G x 1.5 syringe, Shinchang medical co., Korea).
Bee venom pharmacopuncture
Bee venom pharmacopuncture was administered only after confirming a negative response to hypersensitivity skin tests. Diluted bee venom (saline:bee venom ratio, 10,000:1) filtered for allergens was injected at 4-5 acupoints proximal to the painful site at the physician's discretion. Each acupuncture point was injected to a total of 0.5-1 cc using disposable injection needles (CPL, 1 cc, 26G x 1.5 syringe, Shinchang medical co., Korea).
Chuna manipulation
Chuna is a Korean version of spinal manipulation that incorporates spinal manipulation techniques for mobilization involving high-velocity, low amplitude thrusts to joints slightly beyond the passive range of motion and gentle force to joints within the passive range of movement. Chuna manipulation was administered 3-5 times a week to pelvic, lumbar, thoracic, and cervical vertebrae at the physician's discretion.

Locations

Country Name City State
Korea, Republic of Jaseng Medical Foundation Bucheon Gyeonggi Province

Sponsors (1)

Lead Sponsor Collaborator
Jaseng Medical Foundation

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Area of disc herniation at disc level most relevant to patient symptoms on MR sagittal and axial view Comparison of disc herniation in MRI between the baseline and post-treatment. Change from baseline MRI (taken before treatment) at post-treatment completion MRI at average of 9 months
Secondary Level of disc degeneration at disc level most relevant to patient symptoms on MR sagittal and axial view Level of disc degeneration at disc level most relevant to patient symptoms on MR sagittal and axial view will be classified into 5 levels according to the method suggested by Pfirrmann et al. Change from baseline MRI (taken before treatment) at post-treatment completion MRI at average of 9 months
Secondary Level of disc herniation at disc level most relevant to patient symptoms on MR sagittal and axial view Level of disc herniation at disc level most relevant to patient symptoms on MR sagittal and axial view will be divided into 4 levels: protrusion, extrusion, sequestration, and migration Change from baseline MRI (taken before treatment) at post-treatment completion MRI at average of 9 months
Secondary Level of herniated disc migration in patients with disc migration at disc level most relevant to patient symptoms on MR sagittal and axial view Level of herniated disc migration in patients with disc migration will be categorized into 3 levels in accordance with the Komori classification Change from baseline MRI (taken before treatment) at post-treatment completion MRI at average of 9 months
Secondary Modic type change at vertebrae adjacent to disc level most relevant to patient symptoms on MR sagittal and axial view Modic type change at vertebrae adjacent to disc level most relevant to patient symptoms on MR sagittal and axial view will be classified into Modic types 0, 1, 2, and 3 Change from baseline MRI (taken before treatment) at post-treatment completion MRI at average of 9 months
Secondary Modic type change location with regard to disc level most relevant to patient symptoms on MR sagittal and axial view Location of modic type change at the vertebrae adjacent to the herniated disc is classified by whether it is above, below, neither above nor below, or both above and below the disc level most relevant to patient symptoms on MR sagittal and axial view Change from baseline MRI (taken before treatment) at post-treatment completion MRI at average of 9 months
Secondary Pain NRS at site of chief complaint Low back pain NRS or neck pain NRS Change from baseline MRI (taken before treatment) at post-treatment follow-up phone interview at average of 3 years
Secondary Radiating pain NRS associated with site of chief complaint Radiating leg pain NRS or radiating arm pain NRS Change from baseline MRI (taken before treatment) at post-treatment follow-up phone interview at average of 3 years
Secondary Whether or not patient has been recommended for surgery regarding pain at site of chief complaint Whether or not patient has been recommended for surgery regarding pain at site of chief complaint will be recorded dichotomously Post-treatment follow-up phone interview at average of 3 years
Secondary Whether or not pain has recurred for 1 month or longer at site of chief complaint Whether or not low back pain, radiating leg pain, neck pain or radiating arm pain has recurred at site of chief complaint will be recorded dichotomously Post-treatment follow-up phone interview at average of 3 years
Secondary Type of treatment received, if any, for pain recurrence for 1 month or longer at site of chief complaint Type of treatment received, if any, for pain recurrence at site of chief complaint out of Korean medicine treatment, conventional nonsurgical treatment, or surgery will be recorded Post-treatment follow-up phone interview at average of 3 years
Secondary Whether or not patient was aware of possible spontaneous disc resorption at site of chief complaint at onset Whether or not patient is aware of possible spontaneous disc resorption at site of chief complaint will be recorded dichotomously Post-treatment follow-up phone interview at average of 3 years
Secondary Type of treatment patient would recommend to others as primary care Type of treatment patient would recommend to others out of surgical and nonsurgical treatment will be recorded Post-treatment follow-up phone interview at average of 3 years
Secondary Satisfaction with integrative Korean medicine treatment Satisfaction with integrative Korean medicine treatment will be recorded using a 5-point Likert scale: very dissatisfied, dissatisfied, slightly satisfied, satisfied, very satisfied Post-treatment follow-up phone interview at average of 3 years
Secondary Korean medicine treatment method perceived to be most effective Korean medicine treatment method perceived to be most effective out of herbal medicine, pharmacopuncture/bee venom pharmacopuncture, acupuncture, and Chuna manipulation will be recorded Post-treatment follow-up phone interview at average of 3 years